Overview
Hereditary cancer syndromes are genetic alterations that increase the risk of developing certain types of cancer. Many of these syndromes are inherited, meaning they are passed down through family generations. Common hereditary cancer syndromes include familial breast cancer, hereditary non-polyposis colorectal cancer (HNPCC), Li-Fraumeni syndrome, and Lynch syndrome. Knowing about hereditary cancer syndromes can help individuals and their families take proactive steps to reduce their risk. This includes lifestyle changes, genetic testing, and increased surveillance, such as more frequent cancer screenings. By recognizing the signs and symptoms of hereditary cancer syndromes and understanding the risks, individuals can work with their healthcare providers to make informed decisions about their health and well-being.
Research published in this journal
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Targeting Mutational Landscape of TP53 in patients diagnosed with Oral Cancer living in Senegal
Functional, Structural and Contextual Analysis of a Variant of Uncertain Clinical Significance in BRCA1: c.5434C->G (p. Pro1812Ala)
How this research is being cited
The 3 articles above have been cited 18 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Genes
-
2025 · Open Journal of Genetics
-
2023 · Cells
-
2023 · Cells
-
2023 · CPT Pharmacometrics & Systems Pharmacology
-
2023 · CPT: Pharmacometrics & Systems Pharmacology
-
2021 · Seminars in Cancer Biology
-
2021 · Novel Approaches in Cancer Study
A sample of recent works citing this journal's research on Hereditary Cancer Syndromes, linking to each citing work.